Feasibility of Trastuzumab-Deruxtecan in the Treatment of Ovarian Cancer: A Systematic Review.
- DOI
- 10.3390/jcm14238483
- Published
- 2025 Nov 29
- Container
- Journal of clinical medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/jcm14238483,
title = {Feasibility of Trastuzumab-Deruxtecan in the Treatment of Ovarian Cancer: A Systematic Review.},
author = {Orzelska J and Trzcińska A and Gierulska N and Lachowska K and Mazur K and Tarkowski R and Puzio I and Tomaszewska E and Kułak A and Kułak K},
year = {2025},
journal = {Journal of clinical medicine},
doi = {10.3390/jcm14238483},
url = {https://doi.org/10.3390/jcm14238483}
}RIS
TY - JOUR TI - Feasibility of Trastuzumab-Deruxtecan in the Treatment of Ovarian Cancer: A Systematic Review. AU - Orzelska J AU - Trzcińska A AU - Gierulska N AU - Lachowska K AU - Mazur K AU - Tarkowski R AU - Puzio I AU - Tomaszewska E AU - Kułak A AU - Kułak K PY - 2025 JO - Journal of clinical medicine DO - 10.3390/jcm14238483 UR - https://doi.org/10.3390/jcm14238483 ER -
APA
J, O., A, T., N, G., K, L., K, M., R, T., I, P., E, T., A, K., & K, K. (2025). Feasibility of Trastuzumab-Deruxtecan in the Treatment of Ovarian Cancer: A Systematic Review.. Journal of clinical medicine. https://doi.org/10.3390/jcm14238483
Source records
- pubmed · retrieved 2026-09-27T09:39:00.981Z